BerandaEXAS • NASDAQ
add
Exact Sciences Corp
Tutup sebelumnya
$69,59
Rentang hari
$68,65 - $70,36
Rentang tahun
$38,88 - $72,81
Kapitalisasi pasar
13,09 M USD
Volume Rata-Rata
2,47 jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 811,08 jt | 15,99% |
Biaya operasional | 559,69 jt | 6,92% |
Penghasilan bersih | -1,18 jt | 92,50% |
Margin laba bersih | -0,15 | 93,36% |
Penghasilan per saham | 0,10 | 272,84% |
EBITDA | 58,04 jt | 225,11% |
Tarif pajak efektif | -1.978,95% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 858,44 jt | -9,33% |
Total aset | 5,80 M | -13,13% |
Total liabilitas | 3,33 M | -4,39% |
Total ekuitas | 2,47 M | — |
Saham yang beredar | 189,32 jt | — |
Harga terhadap nilai buku | 5,33 | — |
Tingkat pengembalian aset | 0,12% | — |
Tingkat pengembalian modal | 0,14% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -1,18 jt | 92,50% |
Kas dari operasi | 89,02 jt | -16,86% |
Kas dari investasi | 224,90 jt | 252,86% |
Kas dari pembiayaan | -4,51 jt | -102,01% |
Perubahan kas bersih | 309,97 jt | 68,25% |
Arus kas bebas | 17,70 jt | -56,35% |
Tentang
Exact Sciences Corp. is an American molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer. Since then Exact Sciences has grown its product portfolio to encompass other screening and precision oncological tests for other types of cancer. Wikipedia
CEO
Didirikan
1 Jan 1995
Kantor pusat
Situs
Karyawan
6.950
